Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRM5 | P41594 | 1/20 | 0.55 |
| ▸ | GRM1 | Q13255 | 1/20 | 0.55 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.55 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.55 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | CA9 | Q16790 | 1/20 | 0.31 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL10875068 | 0.96 | GRM5 (0.52) | GRM5GRM1GRM2GRM4 | |
| SCHEMBL20130279 | 0.87 | GRM5 (0.46) | GRM5GRM1GRM2GRM4FFAR3 | |
| SCHEMBL15055615 | 0.84 | GRM5 (0.50) | GRM5GRM1GRM2GRM4 | |
| SCHEMBL16887658 | 0.84 | GRM5 (0.44) | GRM5GRM1GRM2GRM4FFAR3 | |
| SCHEMBL4732666 | 0.82 | GRM5 (0.42) | GRM5GRM1GRM2GRM4 | |
| Hydrochloric Acid SCHEMBL26963918 | 0.82 | GRM4 (0.48) | GRM5GRM1GRM2GRM4 | |
| Hydrochloric Acid SCHEMBL10875811 | 0.79 | GRM5 (0.41) | GRM5GRM1GRM2GRM4 | |
| SCHEMBL5313701 | 0.78 | GRM5 (0.40) | GRM5GRM1GRM2GRM4 | |
| SCHEMBL16886352 | 0.78 | GRM5 (0.45) | GRM5GRM1GRM2GRM4 | |
| SCHEMBL10875010 | 0.78 | GRM5 (0.45) | GRM5GRM1GRM2GRM4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 82 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116987102-A | Preparation of complex with thermal activation delayed fluorescence property and application of scintillator | 南开大学 | 2023-11-03 | — | — | CN | claimed |
| EP-3704094-B1 | MODULATORS OF THE INTEGRATED STRESS PATHWAY | CALICO LIFE SCIENCES LLC (US) | 2026-03-11 | — | — | EP | disclosed |
| CN-121574071-A | Binary hydroxamic acid compound, rare earth metal organic framework material, and preparation methods and applications thereof | 浙江大学衢州研究院 | 2026-02-27 | — | — | CN | disclosed |
| WO-2025137053-A1 | WEE1 DEGRADING COMPOUNDS AND USES THEREOF | BRISTOL-MYERS SQUIBB COMPANY (US) | 2025-06-26 | — | — | WO | disclosed |
| US-20250197374-A1 | WEE1 DEGRADING COMPOUNDS AND USES THEREOF | BRISTOL-MYERS SQUIBB COMPANY | 2025-06-19 | — | — | US | disclosed |
| US-20250122188-A1 | MODULATORS OF THE INTEGRATED STRESS PATHWAY | CALICO LIFE SCIENCES LLC (US) | 2025-04-17 | — | — | US | disclosed |
| WO-2025079720-A1 | HALOGENATED CUBANE COMPOUND AND PRODUCTION METHOD FOR SAME | ＡＧＣ株式会社 | 2025-04-17 | — | — | WO | disclosed |
| US-20240166652-A1 | MODULATORS OF THE INTEGRATED STRESS PATHWAY | ABBVIE INC. | 2024-05-23 | — | — | US | disclosed |
| US-20240140939-A1 | COMPOSITIONS AND METHODS FOR REDUCING PHOTO DAMAGE DURING SEQUENCING | ILLUMINA, INC. | 2024-05-02 | — | — | US | disclosed |
| EP-4356971-A2 | MODULATORS OF THE INTEGRATED STRESS PATHWAY | Calico Life Sciences LLC (US) | 2024-04-24 | — | — | EP | disclosed |
| WO-2001066147-A2 | ANTIMICROBIAL COMPOUNDS AND FORMULATIONS | ALPHARMA AS (NO) | 2001-09-13 | — | — | WO | disclosed |
| EP-1109831-A2 | CYCTOTOXIC PEPTIDES MODIFIED BY BULKY OR LIPOPHILIC MOIETIES | ALPHARMA AS (NO) | 2001-06-27 | — | — | EP | disclosed |
| EP-1109827-A2 | BIOACTIVE PEPTIDES | ALPHARMA AS (NO) | 2001-06-27 | — | — | EP | disclosed |
| WO-2000012541-A2 | CYTOTOXIC PEPTIDES MODIFIED BY BULKY OR LIPOPHILIC MOIETIES | ALPHARMA AS (NO) | 2000-03-09 | — | — | WO | disclosed |
| WO-2000012542-A2 | CYTOTOXIC LACTOFERRIN DERIVATIVES MODIFIED BY BULKY OR LIPOPHILIC MOIETIES | ALPHARMA AS (NO) | 2000-03-09 | — | — | WO | disclosed |
| EP-0324609-B1 | OXIDIZING SALTS OF CUBYL AMINES | THIOKOL CORPORATION (US) | 1992-03-25 | — | — | EP | disclosed |
| US-4878968-A | LIQUID PROPELLANTS | MORTON THIOKOL, INC. (US) | 1989-11-07 | — | — | US | disclosed |
| EP-0324609-A1 | Oxidizing salts of cubyl amines | THIOKOL CORPORATION (US) | 1989-07-19 | — | — | EP | disclosed |
| EP-0181926-A1 | SUBSTITUTED CUBANES | UNIVERSITY PATENTS, INC. (US) | 1986-05-28 | — | — | EP | disclosed |
| WO-1985005357-A1 | SUBSTITUTED CUBANES | UNIVERSITY PATENTS, INC. (US) | 1985-12-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240140939-A1 | COMPOSITIONS AND METHODS FOR REDUCING PHOTO DAMAGE DURING SEQUENCING | OGG1, POLL, POLRMT | GRM5 3969/4885GRM1 4585/4885GRM2 4288/4885 |
| US-20250122188-A1 | MODULATORS OF THE INTEGRATED STRESS PATHWAY | ATF4, ATF1, DDIT3 | GRM5 1226/4885GRM1 1417/4885GRM2 875/4885 |
| US-20240166652-A1 | MODULATORS OF THE INTEGRATED STRESS PATHWAY | ATF4, ATF1, DDIT3 | GRM5 1226/4885GRM1 1417/4885GRM2 875/4885 |
| US-20250197374-A1 | WEE1 DEGRADING COMPOUNDS AND USES THEREOF | WEE1, WEE2, PPME1 | GRM5 4137/4885GRM1 3904/4885GRM2 3779/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.